Archon Capital Management LLC Harvard Bioscience Inc Transaction History

Archon Capital Management LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$4.02 - $5.39 $74,369 - $99,715	-18,500 Reduced 6.62%	260,858 $1.11 Million
Q2 2023 Aug 11, 2023	SELL	$4.19 - $6.16 $4.54 Million - $6.67 Million	-1,082,411 Reduced 79.49%	279,358 $1.53 Million
Q4 2022 Feb 13, 2023	BUY	$2.12 - $2.86 $119,237 - $160,857	56,244 Added 4.31%	1,361,769 $3.77 Million
Q3 2022 Nov 10, 2022	BUY	$2.33 - $3.92 $813,284 - $1.37 Million	349,049 Added 36.49%	1,305,525 $3.34 Million
Q2 2022 Aug 15, 2022	BUY	$3.28 - $6.42 $886,387 - $1.73 Million	270,240 Added 39.38%	956,476 $3.44 Million
Q4 2021 Feb 14, 2022	SELL	$6.37 - $8.18 $318,500 - $409,000	-50,000 Reduced 6.79%	686,236 $4.84 Million
Q3 2021 Nov 15, 2021	SELL	$6.98 - $8.47 $61,305 - $74,392	-8,783 Reduced 1.18%	736,236 $5.14 Million
Q2 2021 Aug 16, 2021	SELL	$5.44 - $8.4 $744,056 - $1.15 Million	-136,775 Reduced 15.51%	745,019 $6.21 Million
Q3 2020 Nov 13, 2020	BUY	$2.75 - $4.2 $175,301 - $267,733	63,746 Added 7.79%	881,794 $2.65 Million
Q2 2020 Aug 14, 2020	BUY	$2.12 - $3.14 $1.73 Million - $2.57 Million	818,048 New	818,048 $2.54 Million

31.5M

700

2.1K

Ticker HBIO
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 41,636,500
Market Cap $90.4M
Description
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...

Get notified when there are updates to the investment portfolio of Archon Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Archon Capital Management LLC with notifications on news.